http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100907202-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 |
filingDate | 2005-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100907202-B1 |
titleOfInvention | Novel phthalazinone derivatives as aurora-A kinase inhibitors |
abstract | It is an object of the present invention to provide a compound of formula (I), a pharmaceutically acceptable salt thereof, enantiomeric forms, stereoisomers and racemates, the preparation of the compounds mentioned above, the medicaments containing them and the preparation thereof, and And control or prevention of diseases such as cancer. |
priorityDate | 2004-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 729.